Natco Pharma’s Kothur unit classified as ‘voluntary action indicated’ by US regulator

Natco Pharma’s Kothur unit classified as ‘voluntary action indicated’ by US regulator

Natco Pharma Ltd on Thursday said it has received an establishment inspection report from the US health regulator for its Kothur unit in Hyderabad, classifying the facility as ‘voluntary action indicated’. The US Food and Drug Administration (FDA) had conducted an inspection at the company’s pharma division located in Kothur, Hyderabad, Natco Pharma said in…

Read More